Patent application number | Description | Published |
20080280946 | Azaindole-Derivatives As Factor Xa Inhibitors - Indazole-derivatives as factor Xa inhibitors The present invention relates to compounds of the formula I | 11-13-2008 |
20090247509 | Novel Heterocyclic Substituted Carbonyl Derivatives and Their Use as Dopamine D3 Receptor Ligands - The invention relates to heterocyclic substituted carbonyl derivatives that display selective binding to dopamine D | 10-01-2009 |
20090281084 | PHENYL-1,2,4-OXADIAZOLONE DERIVATIVES WITH PHENYL GROUP, PROCESSES FOR THEIR PREPARATION AND THEIR USE AS PHARMACEUTICALS - The invention relates to phenyl-1,2,4-oxadiazolone derivatives with phenyl group and to their physiologically acceptable salts and physiologically functional derivatives showing PPARdelta agonist activity. | 11-12-2009 |
20090298871 | SULFONYL-PHENYL-2H-[1,2,4]OXADIAZOL-5-ONE DERIVATIVES , PROCESSES FOR THEIR PREPARATION AND THEIR USE AS PHARMACEUTICALS - The invention relates to sulfonyl-phenyl-oxadiazolones and to their physiologically acceptable salts and physiologically functional derivatives showing PPARdelta or PPARdelta and PPARgamma agonist activity. | 12-03-2009 |
20100022603 | BICYCLIC ARYL-SULFONIC ACID [1,3,4]-THIADIAZOL-2-YL-AMIDES, PROCESSES FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR THEIR USE - The present invention comprises bicyclic aryl-sulfonic acid [1,3,4]-thiadiazol-2-yl-amides, their functional derivatives thereof as well as their physiologically acceptable salts and pharmaceutical compositions thereof that exhibit peroxisome proliferator activated receptor (PPAR) PPARdelta and PPARgamma agonist activity. The structure of the compounds of the invention are defined by Formula I below, | 01-28-2010 |
20100144862 | USE OF SUBSTITUTED PYRANONE ACID DERIVATIVES FOR THE TREATMENT OF METABOLIC SYNDROME - The invention relates to the use of substituted pyranone acid derivatives and of their physiologically acceptable salts for producing medicaments for treating the metabolic syndrome. | 06-10-2010 |
20100168429 | Transition metal catalyzed synthesis of N-aminoindoles - The present invention relates to a process for the regioselective synthesis of compounds of the formula I, | 07-01-2010 |
20100216988 | Regioselective metal catalyzed synthesis of annelated benzimidazoles and azabenzimidazoles - The present invention relates to a process for the regioselective synthesis of compounds of the formula I, | 08-26-2010 |
20100234601 | Transition metal catalyzed synthesis of 2H-indazoles - The present invention relates to a process for the regioselective synthesis of compounds of the formula I, | 09-16-2010 |
20100261900 | Process for the palladium-catalyzed coupling of terminal alkynes with heteroaryl tosylates and heteroaryl benzenesulfonates - A process for the palladium-catalyzed coupling of terminal alkynes with heteroaryl tosylates and heteroaryl benzenesulfonates | 10-14-2010 |
20100261909 | Regioselective copper catalyzed synthesis of benzimidazoles and azabenzimidazoles - The present invention relates to a process for the regioselective synthesis of compounds of the formula I, | 10-14-2010 |
20100261910 | Process for the palladium-catalyzed coupling of terminal alkynes with aryl tosylates - The present invention relates to a process for the regioselective synthesis of compounds of the formula (I), | 10-14-2010 |
20110224263 | Cyclic pyridyl-N-[1,3,4]-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals - The invention relates to cyclic N-[1,3,4]-thiadiazol-2-yl-benzene sulfonamides and to their physiologically acceptable salts and physiologically functional derivatives showing PPARdelta or PPARdelta and PPARgamma agonist activity. | 09-15-2011 |